Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT07182045
- Status
- Recruiting
Conditions
- Myoma
- Surgery
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Temporary clamping of uterine and ovarian vessels — OTHERSurgeon will temporarily clamp uterine and ovarian vessels.
Study Details
This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.
Key Dates
- Start date
- Sep 18, 2025
- Status verified
- May 2026
- Primary completion
- Sep 30, 2028
- Completion
- Sep 30, 2029
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Temporary vessel clampsUse of temporary laparoscopic vessel clamps on uterine and ovarian vessels
- No Intervention: No Temporary vessel clampsNo use of vessel clamps
Primary Outcome Measure
Estimated blood loss [ Time Frame: Intraoperative (during surgery, which is < 24 hours) ]
Central Contacts
- Randa Jalloul, MD3137128603
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Hermann Hospital | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By research site
Related Studies
- The Pediatric Anesthesia Quality Improvement ProjectRecruiting · The Society for Pediatric Anesthesia · Phoenix, Arizona
- Sentinel Node Biopsy in Endometrial CancerPHASE3 · Recruiting · Queensland Centre for Gynaecological Cancer · Houston, Texas
- Terumo Aortic Global Endovascular RegistryRecruiting · Vascutek Ltd. · Long Beach, California
- Evaluation of Resection Techniques for Pancreatic TumorsRecruiting · Methodist Health System · Dallas, Texas